{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-122575","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.007181+00:00","generated_at":"2026-05-30T03:50:54.204450+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"LifeStance Q3 revenue $312.7M (+19% YoY); raises FY2024 guidance on Adj. EBITDA to $105-115M","bullets":["Revenue $312.7M (+19% YoY); net loss improved to $6.0M from $61.6M; Adjusted EBITDA $30.7M (+110%).","Clinician base 7,269 (+13% YoY); visit volumes 2.0M (+15%); Center Margin $100.4M (32.1% of revenue, +32%).","FY2024 guidance raised: revenue $1.228B-$1.248B; Adj. EBITDA $105M-$115M; positive Free Cash Flow reiterated.","Q4 2024 guidance: revenue $302.5M-$322.5M; Adj. EBITDA $18M-$28M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-122575","json":"https://secwatch.observer/filing/0000950170-24-122575.json","markdown":"https://secwatch.observer/filing/0000950170-24-122575.md","text":"https://secwatch.observer/filing/0000950170-24-122575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024122575/0000950170-24-122575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024122575/lfst-20241107.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:50:54.204450+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}